NCT04264416 is a NA clinical trial of WB-EMS in Golf Specific Performance, sponsored by University of Erlangen-Nürnberg Medical School.

Who is sponsoring NCT04264416?

NCT04264416 is sponsored by University of Erlangen-Nürnberg Medical School.

What drugs are being tested in NCT04264416?

Interventions in NCT04264416: WB-EMS.

What condition does NCT04264416 study?

NCT04264416 studies Golf Specific Performance, Muscle Strength, Trunk Stability.

Is NCT04264416 still recruiting?

NCT04264416 is currently completed. Last updated 11 January 2021.

Last reviewed 2021-01-11 · How we verify

NCT04264416

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Whole-Body Electromyostimulation on Golf Performance

Completed NA Last updated 11 January 2021

What this trial tests

NA trial testing WB-EMS in Golf Specific Performance in 50 participants. Completed in 31 December 2020.

Timeline

20 January 2020

Primary endpoint
30 December 2020

31 December 2020

Quick facts

Lead sponsor	University of Erlangen-Nürnberg Medical School
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	50
Start date	20 January 2020
Primary completion	30 December 2020
Estimated completion	31 December 2020
Sites	1 location across Germany

Drugs / interventions tested

WB-EMS

Conditions studied

Golf Specific Performance — all drugs for Golf Specific Performance →
Muscle Strength — all drugs for Muscle Strength →
Trunk Stability — all drugs for Trunk Stability →

Sponsor

University of Erlangen-Nürnberg Medical School

Who can join

Adults 18 to 70, male only, with Golf Specific Performance or Muscle Strength. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Golf is becoming increasingly popular in Germany. However, the biomechanical and motor challenge of golf should not be underestimated. Nevertheless, only very few amateur golfers carry out serious preparation and conditioning as part of a strength/stabilization program. The main argument for this limitation is the aspect of "limited time resources". A solution to this problem could therefore be the time-effective and highly individualizable whole-body electromyostimulation (WB-EMS) technology. The aim of the present study is to evaluate the effectiveness of 16 weeks of WB-EMSapplication on maximum strength of the lower extremities, trunk stability and (golf) handicap in male amateur golfers in a (randomized) controlled setting.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

The effect of ageing on fat infiltration of thigh and paraspinal muscles in men.
Engelke K, Ghasemikaram M, Chaudry O, Uder M, et al · · 2022 · cited 34× · PMID 35633478 · DOI 10.1007/s40520-022-02149-1
Once-Weekly Whole-Body Electromyostimulation Increases Strength, Stability and Body Composition in Amateur Golfers. A Randomized Controlled Study.
Zink-Rückel C, Kohl M, Willert S, von Stengel S, et al · · 2021 · cited 9× · PMID 34070315 · DOI 10.3390/ijerph18115628
Once Weekly Whole-Body Electromyostimulation Enhances Muscle Quality in Men: Data of the Randomized Controlled Franconian Electromyostimulation and Golf Study.
Zink-Rückel C, Chaudry O, Engelke K, Ghasemikaram M, et al · · 2021 · cited 6× · PMID 34366890 · DOI 10.3389/fphys.2021.700423

Verify or expand the search:

Other trials of WB-EMS

Trials testing the same drug.

NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
NCT04967534 — Efficacy of WB-EMS in Frail Older People · NA · completed
NCT04065815 — Protein-rich Nutritional Therapy Combined With Time-efficient Exercise in Cancer Therapy · NA · unknown
NCT03767088 — Whole-body Electromyostimulation in Inpatient Rehabilitation · NA · completed
NCT05218512 — WB-EMS Increase Energy Expenditure at Rest and During Uphill Walking Exercise · completed

Other University of Erlangen-Nürnberg Medical School trials

Trials by the same sponsor.

NCT06969820 — Establishment and Evaluation of Standardized Clinical, Biological and Imaging Parameters to Assess the Response of LDRT · not yet recruiting
NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
NCT07352540 — Single vs Triple Hyaluronic Acid in Knee Osteoarthritis · Phase 2, PHASE3 · not yet recruiting
NCT07313878 — Evaluation of Acute and Chronic Nephrotoxicity in Acute Lymphatic Leukemia Patients Using Ultrasound Localization Micros · NA · recruiting
NCT07121985 — Multispectral Optoacoustic Imaging for the Detection of Inflammation and Damage of Peripheral Nerves in Guillain-Barré S · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04264416 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Erlangen-Nürnberg Medical School
Last refreshed: 11 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04264416.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing